Page last updated: 2024-08-16

meptazinol and Amentia

meptazinol has been researched along with Amentia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, HZ; Ge, XX; Jiang, P; Le, WD; Lu, Y; Qiu, ZB; Shao, BY; Sun, J; Wang, H; Xia, Z; Xie, Q; Zhang, WW	1

Other Studies

1 other study(ies) available for meptazinol and Amentia

Article	Year
Meserine, a novel carbamate AChE inhibitor, ameliorates scopolamine-induced dementia and alleviates amyloidogenesis of APP/PS1 transgenic mice. CNS neuroscience & therapeutics, 2014, Volume: 20, Issue:2 Topics: Acetylcholinesterase; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloidosis; Animals; Cell Line, Tumor; Cholinesterase Inhibitors; Dementia; Disease Models, Animal; Drug Administration Schedule; Humans; Maze Learning; Meptazinol; Mice; Mice, Transgenic; Neuroblastoma; Phenylcarbamates; Presenilin-1; RNA, Messenger; Scopolamine	2014

Article

Year

Meserine, a novel carbamate AChE inhibitor, ameliorates scopolamine-induced dementia and alleviates amyloidogenesis of APP/PS1 transgenic mice.

CNS neuroscience & therapeutics, 2014, Volume: 20, Issue:2

Topics: Acetylcholinesterase; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloidosis; Animals; Cell Line, Tumor; Cholinesterase Inhibitors; Dementia; Disease Models, Animal; Drug Administration Schedule; Humans; Maze Learning; Meptazinol; Mice; Mice, Transgenic; Neuroblastoma; Phenylcarbamates; Presenilin-1; RNA, Messenger; Scopolamine

2014